15 Results

People

  1. Heller
    Heller
  2. Sadelain
    Sadelain
  3. Riviere
    Riviere
  4. Brentjens
    Brentjens
  5. O'Reilly
    O'Reilly
  6. Wang
    Wang
  7. Bartido
    Bartido
  8. Latouche
    Latouche
  9. May
    May
  10. Taylor
    Taylor

Groups

  1. Biostatistics Service (15)
  2. Center for Hematologic Malignancies (15)
  3. Department of Medicine (15)
  4. Epidemiology and Biostatistics (15)
  5. GSK Faculty (15)
  6. Hematologic Malignancies Research (15)
  7. Hematologic Malignancies, Division of (15)
  8. Molecular Pharmacology and Chemistry Program Faculty (15)
  9. Sloan Kettering Institute Faculty (15)
  10. Immunology Program Faculty (6)
  1. "Hematologic Malignancies Research"
  2. "Center for Hematologic Malignancies"
  3. "Michel Sadelain"
  4. "Glenn Heller"
Formats
  1. Journal Article (12)
  2. Meeting Abstract (3)
Groups
  1. Biostatistics Service (15)
  2. Center for Hematologic Malignancies (15)
  3. Department of Medicine (15)
  4. Epidemiology and Biostatistics (15)
  5. GSK Faculty (15)
  6. Hematologic Malignancies Research (15)

More Groups

People
  1. Glenn Heller (15)
  2. Michel Sadelain (15)
  3. Isabelle Riviere (10)
  4. Renier Brentjens (5)
  5. Richard O'Reilly (4)
  6. Xiuyan Wang (4)

More People

Years
  1. 2023 (1)
  2. 2019 (1)
  3. 2016 (1)
  4. 2014 (1)
  5. 2013 (1)
  6. 2011 (2)

More Years

Publications
  1. Blood (4)
  2. Molecular Therapy (2)
  3. Nature Biotechnology (2)
  4. Cancer Research (1)
  5. Clinical and Experimental Immunology (1)
  6. Immunity (1)

More Publications

Publishers
  1. Nature Publishing Group (6)
  2. American Society of Hematology (4)
  3. American Association for Cancer Research (1)
  4. British Society for Immunology (1)
  5. Cell Press (1)
  6. Lippincott Williams & Wilkins (1)

More Publishers

Results (15)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The ectonucleotidase CD39 identifies tumor-reactive CD8(+) T cells predictive of immune checkpoint blockade efficacy in human lung cancer
    Journal Article

    Chow, A.; Uddin, F. Z.; Liu, M.; Dobrin, A.; Nabet, B. Y.; Mangarin, L.; Lavin, Y.; Rizvi, H.; Tischfield, S. E.; Quintanal-Villalonga, A.; more...
    Immunity (2023)

    Fulltext@MSK | Save
  • Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL
    Journal Article

    Curran, K. J.; Margossian, S. P.; Kernan, N. A.; Silverman, L. B.; Williams, D. A.; Shukla, N.; Kobos, R.; Forlenza, C. J.; Steinherz, P.; Prockop, S.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Soluble and membrane-bound interleukin (IL)-15 Rα/IL-15 complexes mediate proliferation of high-avidity central memory CD8(+) T cells for adoptive immunotherapy of cancer and infections
    Journal Article

    Hasan, A. N.; Selvakumar, A.; Shabrova, E.; Liu, X. R.; Afridi, F.; Heller, G.; Riviere, I.; Sadelain, M.; Dupont, B.; O'Reilly, R. J.
    Clinical and Experimental Immunology (2016)

    Fulltext@MSK | Save
  • Safe mobilization of CD34+ cells in adults with β-thalassemia and validation of effective globin gene transfer for clinical investigation
    Journal Article

    Boulad, F.; Wang, X.; Qu, J.; Taylor, C.; Ferro, L.; Karponi, G.; Bartido, S.; Giardina, P.; Heller, G.; Prockop, S. E.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Safe G-CSF mobilization of thalassemia patient CD34+cells and effective globin gene transduction for therapeutic infusion
    Meeting Abstract

    Boulad, F.; Wang, X. Y.; Taylor, C.; Qu, J. R.; Ferro, L.; Karponi, G.; Bartido, S.; Giardina, P.; Heller, G.; Prockop, S. E.; more...
    Molecular Therapy (2013)

    Fulltext@MSK | Save
  • Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias
    Journal Article

    Brentjens, R. J.; Riviere, I.; Park, J. H.; Davila, M. L.; Wang, X.; Stefanski, J.; Taylor, C.; Yeh, R.; Bartido, S.; Borquez-Ojeda, O.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • In vivo inhibition of human CD19-targeted effector T cells by natural T regulatory cells in a xenotransplant murine model of B cell malignancy
    Journal Article

    Lee, J. C.; Hayman, E.; Pegram, H. J.; Santos, E.; Heller, G.; Sadelain, M.; Brentjens, R.
    Cancer Research (2011)

    Fulltext@MSK | Save
  • Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors
    Journal Article

    Zakrzewski, J. L.; Suh, D.; Markley, J. C.; Smith, O. M.; King, C.; Goldberg, G. L.; Jenq, R.; Holland, A. M.; Grubin, J.; Cabrera-Perez, J.; more...
    Nature Biotechnology (2008)

    Fulltext@MSK | Save
  • Scalable expansion of potent genetically modified human langerhans cells in a closed system for clinical applications
    Journal Article

    Yuan, J.; Kendle, R.; Ireland, J.; Heller, G.; Sadelain, M.; Young, J. W.; Riviere, I.
    Journal of Immunotherapy (2007)

    Fulltext@MSK | Save
  • T cell-encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejection
    Journal Article

    Stephan, M. T.; Ponomarev, V.; Brentjens, R. J.; Chang, A. H.; Dobrenkov, K. V.; Heller, G.; Sadelain, M.
    Nature Medicine (2007)

    Fulltext@MSK | Save